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Background
Functional enrichment analysis has become a popular
approach for the interpretation of gene lists derived from
large scale genomic, transcriptomic, and proteomic stu-
dies. Many software tools have been developed for this
analysis, including our previously published Web-based
Gene Set Enrichment Analysis Toolkit (WebGestalt) [1].
Major differences among existing tools include: 1) the sta-
tistical test used for the enrichment analysis; 2) supported
organisms; 3) supported input ID types; 4) coverage of
functional categories; and 5) presentation of the output
results. We have made improvements in the above areas
in the updated and expanded version, WebGestalt2.
Materials and methods
First, we have implemented methods for the multiple-
test adjustment. Because we are testing many functional
categories at the same time, multiple-test adjustment
methods have been implemented to correct p-values
generated by the hypergeometic test. Second, although
the original version only supports human and mouse,
the new version has been expanded to cover other
organisms including rat, worm, fly, yeast, dog, and zeb-
rafish. Third, WebGestalt2 supports more input ID
types from various databases and different technology
platforms. For example, 32 ID types are supported for
human and 29 ID types are supported for mouse. The
addition of protein ID types such as the Ensembl pep-
tide ID, the IPI ID, the refseq_peptide ID, and the Uni-
prot ID makes this tool directly available to the fast
growing proteomics community. One of the most
important improvements in WebGestalt2 is the
increased coverage of functional categories in various
biological contexts, including chromosomal location,
Gene Ontology (GO), KEGG pathways, Pathway Com-
mons, Wikipathways, Transcription factor targets,
microRNA targets, and functional modules in protein
interaction networks. WebGestalt2 retains the enriched
directed acyclic graph (DAG) representation for the GO
enrichment analysis results and uses tables for results
from other analyses. WebGestalt2 can also highlight
genes in KEGG pathway maps and Wikipathway maps.
Results and conclusion
WebGestalt2 does not require registration and does not
require a login to upload gene lists. As a result, analysis
results will not be stored on the server. Instead, users
are given options to save their results locally. The code
has been optimized so that the new version is much fas-
ter than the old one and can scale to large input lists
with thousands of genes.
In conclusion, significant improvements have been
made in WebGestalt2 compared to the original version.
The new version provides a simple but powerful plat-
form for the efficient interpretation of gene lists.
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